Skip to main content

UBS 6-K

UBS Group AG (UBS)

6-K 2024-11-08 For: 2024-11-08
View Original
Added on July 04, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 6-K

REPORT OF FOREIGN PRIVATE

ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

Date: November 8, 2024

UBS Group AG

(Registrant's

Name)

Bahnhofstrasse 45, 8001 Zurich, Switzerland

(Address of principal executive office)

Commission File Number: 1-36764

UBS AG

(Registrant's

Name)

Bahnhofstrasse 45, 8001 Zurich, Switzerland

Aeschenvorstadt 1, 4051 Basel, Switzerland

(Address of principal executive offices)

Commission File Number: 1-15060

Indicate by check mark whether the registrants file or will file annual

reports under cover of Form 20-F or Form

40-

F.

Form 20-F

Form 40-F

This Form 6-K consists of UBS supplementary information

for significant regulated subsidiaries and sub-groups

for

the second and third quarters of 2024, which appear immediately following

this page.

edgar00significantregp3i0

Significant regulated subsidiary

and sub-group information

Third quarter

2024

Significant regulated subsidiary and sub-group

information

2

Significant regulated subsidiary

and sub-group information

Unaudited

Financial and regulatory key figures for our significant regulated

subsidiaries and sub-groups

UBS AG

(consolidated)

UBS AG

(standalone)

UBS Switzerland AG

(standalone)

UBS Europe SE

(consolidated)

UBS Americas

Holding LLC

(consolidated)

All values in million, except where indicated

USD

USD

CHF

EUR

USD

Financial and regulatory requirements

IFRS Accounting Standards

Swiss SRB rules

IFRS Accounting

Standards

Swiss SRB rules

IFRS Accounting

Standards

Swiss SRB rules

IFRS Accounting

Standards

EU regulatory rules

US GAAP

US Basel III rules

As of or for the quarter ended

30.9.24

30.6.24

30.9.24

30.6.24

30.9.24

30.6.24

30.9.24

30.6.24

1

30.9.24

30.6.24

2

Financial information

3

Income statement

Total operating income

4

11,831

9,816

5,170

6,825

3,475

2,374

292

286

4,461

4,357

Total operating expenses

10,640

10,012

3,489

3,382

2,303

1,715

263

257

4,177

4,258

Operating profit / (loss) before tax

1,191

(196)

1,681

3,443

1,172

660

29

29

284

99

Net profit / (loss)

997

(224)

1,815

3,652

1,012

561

24

21

122

28

Balance sheet

Total assets

1,626,893

1,564,664

980,770

948,599

537,000

324,079

46,935

48,946

203,427

211,341

Total liabilities

1,529,071

1,470,417

892,651

863,202

511,044

310,703

42,907

44,946

170,824

178,863

Total equity

97,822

94,247

88,119

85,397

25,956

13,376

4,027

4,000

32,603

32,478

Capital

5

Common equity tier 1 capital

84,423

83,001

83,113

82,329

22,016

12,601

2,701

2,740

23,303

23,036

Additional tier 1 capital

16,250

15,132

16,250

15,132

7,993

5,000

600

600

2,817

2,810

Total going concern capital / Tier 1 capital

100,673

98,133

99,363

97,461

30,009

17,601

3,301

3,340

26,121

25,846

Tier 2 capital

289

536

286

531

257

256

Total capital

3,301

3,340

26,378

26,103

Total gone concern loss-absorbing capacity

96,473

98,833

96,470

98,828

20,007

11,238

2,520

6

2,530

6

7,800

7

7,800

7

Total loss-absorbing capacity

197,146

196,966

195,833

196,288

50,016

28,840

5,821

5,870

33,921

7

33,646

7

Risk-weighted assets and leverage

ratio denominator

5

Risk-weighted assets

515,520

509,953

565,180

554,478

185,237

110,294

12,622

12,423

84,944

84,289

Leverage ratio denominator

1,611,151

1,564,001

944,404

921,796

567,484

337,149

50,053

50,630

197,597

205,699

8

Supplementary leverage ratio denominator

227,490

232,968

8

Capital and leverage ratios (%)

5

Common equity tier 1 capital ratio

16.4

16.3

14.7

9

14.8

11.9

11.4

21.4

22.1

27.4

27.3

Going concern capital ratio / Tier 1 capital ratio

19.5

19.2

17.6

17.6

16.2

16.0

26.2

26.9

30.8

30.7

Total capital ratio

26.2

26.9

31.1

31.0

Total loss-absorbing capacity ratio

38.2

38.6

27.0

26.1

46.1

47.2

39.9

39.9

Tier 1 leverage ratio

6.6

6.6

13.2

12.6

Supplementary tier 1 leverage ratio

11.5

11.1

Going concern leverage ratio

6.2

6.3

10.5

10.6

5.3

5.2

Total loss-absorbing capacity leverage ratio

12.2

12.6

8.8

8.6

11.6

11.6

17.2

16.4

Gone concern capital coverage ratio

120.1

127.5

Liquidity coverage ratio

5

High-quality liquid assets (bn)

360.6

280.3

170.2

137.0

126.0

78.1

16.7

17.3

32.1

29.7

10

Net cash outflows (bn)

183.7

143.6

60.4

50.5

86.0

53.6

11.5

11.7

24.6

20.1

10

Liquidity coverage ratio (%)

196.3

194.1

282.3

11

269.5

146.7

12

145.9

145.2

148.3

130.1

147.7

10

Net stable funding ratio

5

Total available stable funding (bn)

903.4

882.8

446.4

448.0

369.2

225.0

14.6

15.1

112.6

107.8

10

Total required stable funding (bn)

712.7

691.5

444.9

437.3

274.0

165.3

11.5

11.6

82.0

79.7

10

Net stable funding ratio (%)

126.8

127.7

100.4

13

102.5

134.7

13

136.1

127.4

129.6

137.3

135.4

10

Other

Joint and several liability between UBS AG and

UBS Switzerland AG (bn)

14

3

15

3

1 Comparative figures have been restated to align with the regulatory reports

as submitted to the European Central Bank.

2 Financial and regulatory information for UBS Americas Holding LLC

is inclusive of Credit

Suisse Holdings (USA), Inc. following the reparenting of this entity under UBS Americas Holding

LLC on 7 June 2024.

3 The financial information disclosed does not represent a full set

of financial statements under

the respective GAAP / IFRS Accounting Standards.

4 The total operating income includes

credit loss expense or release.

5 Refer to the 30 September 2024 Pillar 3 Report, available

under “Pillar 3 disclosures” at

ubs.com/investors, for more information.

6 Consists of positions that meet

the conditions laid down in

Art. 72a–b of the Capital Requirements

Regulation II with regard to contractual,

structural or legal subordination.

7 Consists of eligible long-term debt that meets the conditions specified in 12 CFR § 252.162 of the final TLAC rules. Total loss-absorbing capacity is the sum of tier 1 capital and eligible long-term debt.

8 Leverage

exposure for 30 June 2024 has been

calculated as if the reparenting of

Credit Suisse Holdings (USA), Inc. occurred

on the first day of the

calendar quarter.

9 On a standalone basis as

of 30 September 2024, UBS

AG’s phase-in CET1

capital ratio was 14.7%,

based on risk-weights of 230%

and 320% for Swiss and

foreign participations, respectively.

These risk-weights will increase

to 250% and 400% for Swiss

and foreign

participations in a phased manner until 1 January 2028, contributing to UBS

AG’s fully applied CET1 capital ratio

of 13.3%.

10 The liquidity coverage ratio and net

stable funding ratio for 30 June 2024 have been

calculated based on a simple daily average of the quarter which included

the business activity of Credit Suisse Holdings (USA), Inc. beginning on 7 June

2024.

11 In the third quarter of 2024, the liquidity coverage

ratio (the LCR) of UBS AG was 282.3%, remaining above the prudential requirements communicated by FINMA.

12 In the third quarter of 2024, the LCR of UBS Switzerland AG, which is a Swiss SRB, was 146.7%,

remaining above the prudential requirement communicated by FINMA

in connection with the Swiss Emergency Plan.

13 In accordance with Art. 17h para. 3 and

4 of the Liquidity Ordinance, UBS AG

standalone is

required to maintain a minimum NSFR of at least 80% without taking into account excess

funding of UBS Switzerland AG and 100% after taking into account

such excess funding.

14 Under certain circumstances,

the Swiss Banking Act and FINMA’s

Banking Insolvency Ordinance authorize FINMA to modify,

extinguish or convert to common equity liabilities of a bank

in connection with a resolution or insolvency of such bank.

15 As of 30 September 2024, the amount

consists of a joint and several liability of

UBS Switzerland AG for contractual obligations of

UBS AG related to the establishment of

UBS Switzerland AG (CHF 2.4bn), and

a

joint and several liability of UBS Switzerland AG

related to the merger with Credit Suisse (Schweiz)

AG in connection with the international covered bonds program

(CHF 0.5bn) which was fully collateralized

through

cash deposits from UBS AG.

Significant regulated subsidiary and sub-group

information

3

UBS Group AG

is

a

holding

company

and

conducts

substantially

all

of

its

operations

through

UBS AG

and

subsidiaries thereof. UBS Group AG and

UBS AG have contributed a

significant portion of

their respective capital

to,

and

provide

substantial

liquidity

to,

such

subsidiaries.

Many

of

these

subsidiaries

are

subject

to

regulations

requiring compliance

with minimum

capital, liquidity

and similar requirements.

The tables in

this section summarize

the

regulatory

capital

components

and

capital

ratios

of

our

significant

regulated

subsidiaries

and

sub-groups

determined under the regulatory framework of

each subsidiary’s or sub-group’s home jurisdiction.

Supervisory authorities generally have discretion to impose higher requirements or

to otherwise limit the activities

of subsidiaries. Supervisory

authorities also may

require entities to

measure capital

and leverage ratios

on a stressed

basis and may limit

the ability of

an entity to engage

in new activities or

take capital actions

based on the results

of

those tests.

In August 2024, the Federal Reserve

Board assigned UBS Americas Holding LLC a stress

capital buffer (an SCB) of

9.3%

as

of

1 October

2024

(previously

9.1%)

under

the

Federal

Reserve

Board’s

SCB

rule,

resulting

in

a

total

common equity tier 1 capital

requirement of 13.8%. The

SCB for our

US-based intermediate holding company is

based on the previously

released results of the Federal

Reserve Board’s 2024 Dodd–Frank Act Stress

Test (DFAST),

where UBS Americas

Holding LLC exceeded

the minimum

capital requirements

under the severely

adverse scenario.

Additional information on the above entities is provided in the 30 September

2024

Pillar 3 Report,

available under

“Pillar 3 disclosures” at

ubs.com/investors

.

Credit Suisse International

(standalone)

All values in million, except where indicated

USD

Financial and regulatory requirements

IFRS Accounting Standards

UK regulatory rules

As of or for the quarter ended

30.9.24

30.6.24

Financial information

1

Income statement

Total operating income

2

211

297

Total operating expenses

245

348

Operating profit / (loss) before tax

(34)

(51)

Net profit / (loss)

(34)

(51)

Balance sheet

Total assets

77,206

87,943

Total liabilities

62,492

73,146

Total equity

14,714

14,797

Capital

3

Common equity tier 1 capital

12,945

12,814

Additional tier 1 capital

1,200

1,200

Total going concern capital / Tier 1 capital

14,145

14,014

Tier 2 capital

0

0

Total capital

14,145

14,014

Total gone concern loss-absorbing capacity

4,586

4,586

Total loss-absorbing capacity

18,731

18,600

Risk-weighted assets and leverage ratio

denominator

3

Risk-weighted assets

16,983

19,699

Leverage ratio denominator

55,245

58,250

Capital and leverage ratios (%)

3

Common equity tier 1 capital ratio

76.2

65.1

Going concern capital ratio / Tier 1 capital ratio

83.3

71.1

Total capital ratio

83.3

71.1

Total loss-absorbing capacity ratio

110.3

94.4

Tier 1 leverage ratio

25.6

24.1

Going concern leverage ratio

Total loss-absorbing capacity leverage ratio

33.9

31.9

Liquidity coverage ratio

3

High-quality liquid assets (bn)

15.0

14.6

Net cash outflows (bn)

4.2

4.4

Liquidity coverage ratio (%)

367.2

345.3

Net stable funding ratio

3

Total available stable funding (bn)

21.6

23.4

Total required stable funding (bn)

12.9

16.5

Net stable funding ratio (%)

182.9

150.8

1 The financial information disclosed does not represent a full set of financial statements under the

respective GAAP / IFRS Accounting Standards.

2 The total operating income includes credit loss expense or release.

3 Refer to the 30 September 2024 Pillar 3 Report, available under “Pillar 3 disclosures” at ubs.com/investors,

for more information.

edgar00significantregp6i0

UBS Group AG

PO Box

CH-8098 Zurich

ubs.com

This

Form

6-K

is

hereby

incorporated

by

reference

into

(1)

each

of

the

registration

statements

on

Form

F-3

(Registration Numbers

333-263376 and

333-278934), and

on Form

S-8 (Registration

Numbers 333-200634;

333-

200635;

333-200641;

333-200665;

333-215254;

333-215255;

333-228653;

333-230312;

333-249143

and

333-

272975), and

into each

prospectus outstanding

under any

of the

foregoing registration

statements, (2)

any outstanding

offering circular or similar document issued

or authorized by UBS AG that incorporates by

reference any Forms 6-

K of UBS AG that are

incorporated into its registration

statements filed with the SEC,

and (3) the base prospectus

of

Corporate Asset Backed

Corporation (“CABCO”)

dated June 23,

2004 (Registration

Number 333-111572), the Form

8-K

of

CABCO

filed

and

dated

June

23,

2004

(SEC

File

Number

001-13444),

and

the

Prospectus

Supplements

relating to

the CABCO

Series 2004-101

Trust

dated May

10, 2004

and May

17, 2004

(Registration Number

033-

91744 and 033-91744-05).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the

registrants have duly caused this

report to be signed on their behalf by the undersigned, thereunto duly

authorized.

UBS Group AG

By:_/s/ David Kelly_____________

Name:

David Kelly

Title:

Managing Director

By:_/s/ Ella Campi_____________

Name:

Ella Campi

Title:

Executive Director

UBS AG

By:_/s/ David Kelly_____________

Name:

David Kelly

Title:

Managing Director

By:_/s/ Ella Campi_____________

Name:

Ella Campi

Title:

Executive Director

Date:

November 8, 2024